WHO decision to halt trials of hydroxychloroquine for COVID-19 is not correct: CSIR DG

Video Credit: ANI
Published on May 29, 2020 - Duration: 01:36s

WHO decision to halt trials of hydroxychloroquine for COVID-19 is not correct: CSIR DG

Council of Scientific and Industrial Research (CSIR), Director General Shekhar Mande said that WHO decision to halt trials of hydroxychloroquine for COVID-19 is not correct and it must resume as early as possible.

"The study was published in Lancet on hydroxychloroquine and chloroquine and its effect on COVID-19.

It is an observational study with statical parameters and analysis which is not sufficiently good.

In our letter to the Lancet editor, we have written that the study design and statical interferences are not right therefore study does not deserve any attention of the readers.

We believe that WHO's decision to temporarily halt the trials is not correct and demanded that the clinical trials of hydroxychloroquine for its use in COVID-19 cases must resume as early as possible," said Mande after WHO halts clinical trials of hydroxychloroquine for COVID-19.


You are here

Related videos from verified sources

Watch: CSIR DG writes to WHO, says decision to halt HCQ trials is not correct 03:14
Video credit: HT Digital Content - Published on May 30, 2020 

WHO Pauses Hydroxychloroquine Medical Trials for COVID-19 01:29
Video credit: Cover Video STUDIO - Published on May 28, 2020 

COVID-19: CSIR DG supports ICMR over WHO's decision on HCQ clinical trials 01:43
Video credit: ANI - Published on May 27, 2020 

You might like